InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Smith Karen L., Vice-Président Exécutif et Directeur Médical. Officer active across 5 companies, notably Emergent BioSolutions Inc.. Aggregated, 10 reports have been logged. The latest transaction was disclosed on 19 May 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations10 total
0170,354 shares0
Common Stock
SEC:0001209191-22-032677:0·
€282,66254,193 shares@ €5.215860.5% of flow
Common Stock
SEC:0000899243-22-019793:0·
24,336 shares
Common Stock
SEC:0001209191-22-031508:0·
012,500 shares0
Common Stock
SEC:0001209191-22-014157:0·
1,622 shares
Common Stock
SEC:0001104659-21-142277·
1,622 shares
Common Stock
SEC:0001104659-21-142277:0·
€92,41925,452 shares@ €3.6311100.0% of flow
Common Stock
SEC:0001209191-21-040340·
€92,41925,452 shares@ €3.631119.8% of flow
Common Stock
SEC:0001209191-21-040340:0·
€15,378305 shares@ €50.42030.0038% mcap100.0% of flow
Common Stock
SEC:0001367644-21-000081·
€15,378305 shares@ €50.42030.0038% mcap50.0% of flow
Common Stock
SEC:0001367644-21-000081:0·
10 of 10 declarations
About Smith Karen L.
Karen L. Smith is EVP, Chief Medical Officer at Emergent BioSolutions Inc., Antares Pharma, Inc., and Acceleron Pharma Inc. She oversees medical and strategic initiatives, playing a key role in product development and innovation.
